Noninvasive Methods For Prediction of Esophageal Varices in Children

Status Enrolling by invitation

Clinical Trial Summary

The aim of this study is to use non-invasive methods to identify patients at risk of developing gastrointestinal varices and correlation of these non-invasive methods with the degree of esophageal varices and the presence or absence of risk signs of bleeding such as cherry red spots.

Clinical Trial Description

Portal hypertension is the underlying pathophysiological process that leads to the formation of portosystemic collaterals and heralds the onset of a severe complication: variceal hemorrhage. It is estimated that approximately 50% of pediatric patients with chronic liver disease and 90% of those with extrahepatic portal vein obstruction (EHPVO) will experience gastrointestinal bleeding. Esophagogastroduodenoscopy (EGD) is considered the primary modality for detection and surveillance of esophageal varices (EV) and to determine the risk of bleeding. Varices were graded into four grades I, II, III, and IV according to the Modified Paquet classification. however, invasiveness of the technique and a significant risk associated with sedation on long-term neurological outcomes have limited its use. Many studies have sought to determine clinical, laboratory, or other noninvasive methods that could predict the presence of EV. Preliminary data suggests that laboratory tests such as platelet count, albumin and ultrasonographic parameters such as presence of splenomegaly, spleen size z score and platelet count to spleen size ratio and the clinical prediction rule (CPR; calculated from platelet count, spleen size z-score, and albumin concentration) may be useful as first-line tools for identification of adults and pediatric patients at risk of variceal development and thus reduce the number of unnecessary EGDs. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05781828
Study type	Observational
Source	Assiut University
Contact
Status	Enrolling by invitation
Phase
Start date	March 15, 2023
Completion date	September 1, 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06017102` - Wired Magnetically Assisted Capsule Endoscopy and Esophageal Varices	N/A
Recruiting	`NCT03624517` - Comparison of 24-hours Versus 72-hours of Octreotide Infusion in Preventing Early Rebleed From Esophageal Varices	Phase 4
Recruiting	`NCT03989973` - Two-dimensional Shear-Wave Elastography Evaluate Esophageal Varices Bleeding Risk of Liver Cirrhosis
Completed	`NCT05485714` - Non-invasive Prediction of Esophageal Varices in Patients With Non-Alcoholic Fatty Liver Disease With Advanced Fibrosis
Completed	`NCT01851252` - MBT Versus HVPG in Identifying Responders to Portal Hypertension Therapy	Phase 1
Completed	`NCT01360515` - A Study of Disposable Transnasal Esophagoscope	N/A
Recruiting	`NCT04602663` - Optimal Time for Follow up After Variceal Band Ligation	N/A
Recruiting	`NCT04499898` - Carvedilol Versus Endoscopic Band Ligation for Primary Prophylaxis of Oesophageal Variceal Bleeding	Phase 2/Phase 3
Completed	`NCT00331188` - Use of Sanvar® With Endoscopic Treatment for the Control of Acute Variceal Bleeding	Phase 3
Enrolling by invitation	`NCT02767206` - Evaluation of Gastroesophageal Varices by Transnasal Endoscopy.	N/A
Not yet recruiting	`NCT05199038` - Comparison of 2 Days Versus 5 Days of Octreotide After Endoscopic Therapy in Preventing Early Esophageal Varices Rebleed : A Randomized Controlled Study	Phase 4
Recruiting	`NCT02740166` - Preventing Recurrent Bleeding After Eradication of Esophageal Varices	Phase 4
Completed	`NCT01893541` - PROPRANOLOL PLUS LIGATION REDUCES RECURRENCE OF ESOPHAGEAL VARICES?	Phase 4
Terminated	`NCT00485290` - Effect of Meal on Portal and Esophagus Variceal Pressure	N/A
Completed	`NCT01079416` - Study of Capsule Endoscopy to Determine the Accuracy for Detection of Esophageal Varices	N/A
Completed	`NCT01188733` - Efficacy of Long-acting Octreotide (Sandostatin LAR) in Reducing Portal Pressure in Patients With Cirrhosis	Phase 1/Phase 2
Not yet recruiting	`NCT04254822` - HVPG-Guided Therapy vs Carvedilol Plus Endotherapy for the Prevention of Esophageal Variceal Rebleeding in Cirrhotic Patients	N/A
Recruiting	`NCT03212872` - Blood Ammonia as Predictor for Esophageal Varices and Risk of Bleeding	N/A
Completed	`NCT03748563` - Accuracy of Magnetically Maneuvered Capsule Endoscopy for Detection of EGV in Patients With Cirrhosis	N/A
Completed	`NCT01059396` - Study on B-blockers to Prevent Decompensation of Cirrhosis With HTPortal	Phase 4